mRNA– tag –
-
Targeted Nanoparticles Enhance Anti-Cancer Immune Responses, Reprogramming Macrophages via mRNA Technology with Over 60% Reduction in Immunosuppressive Cells
News-Medical Australia Overview Researchers at the University of Adelaide have developed a groundbreaking method using lipid nanoparticles (LNPs) with mRNA technology to reprogram immune cells within tumors, thereby strengthening the bod... -
Exosome Therapy Revolutionizes Skin Treatment: Promotes Cell Regeneration and Anti-Inflammation Without Physical Injury
Dr Azra Vaziri USA Overview Exosome therapy harnesses tiny extracellular vesicles secreted by stem cells to deliver biological signals for cell repair and regeneration to skin cells. Unlike traditional dermapen or microneedling, this tre... -
AGC Biologics Highlights Strengths as Global CDMO Partner for Biologics and Advanced Therapies
The Economy Global Overview AGC Biologics is recognized as a global biopharmaceutical CDMO providing development and manufacturing services across a wide range of advanced modalities, including biologics, plasmid DNA, mRNA, viral vectors... -
Evonik Invests Over $108 Million in Vancouver GMP Facility, Tripling Lipid-Based Drug Delivery Capacity
bionity.com Canada Overview Evonik announced an investment exceeding CAD 150 million (approximately USD 108 million) into its GMP manufacturing facility in Vancouver, Canada, more than tripling its production capacity for lipid-based dru... -
Evonik Invests $108M in Vancouver GMP Facility, Significantly Expanding Lipid-Based Drug Delivery Manufacturing Capacity
Contract Pharma USA Overview Evonik has announced a significant investment of $108 million into its GMP formulation manufacturing facility in Vancouver, Canada, dedicated to lipid-based drug delivery. This substantial capital injection a... -
Evonik Invests Over C$150 Million in Vancouver LNP Drug Manufacturing Facility, Targeting Late 2029 Launch
Pharmaceutical Outsourcing Canada Overview Evonik is investing over C$150 million (approximately US$110 million) to significantly expand its lipid formulation and lipid nanoparticle (LNP) drug product manufacturing capabilities in Vancou... -
Nanotechnology Revolutionizes Cancer Therapy: Magnetic Nanobots, mRNA Cancer Vaccines, and Gold Nanoparticle Photothermal Treatment Advance
Facebook (Scientific Community Post) Global Overview Nanotechnology is making groundbreaking strides in cancer treatment, with breakthroughs including magnetic nanorobots for targeted drug delivery, mRNA cancer vaccines encapsulated in l... -
BioNTech and Genentech Terminate Phase 2 Personalized Cancer Vaccine Trial Due to Survival Imbalance
Fierce Biotech USA Overview BioNTech and Genentech have cancelled their Phase 2 clinical trial for autogene cevumeran (BNT122), a personalized cancer vaccine targeting colorectal cancer patients, after an independent data safety monitori... -
REPROCELL Accelerates Clinical Production with FDA/EMA/PMDA-Compliant iPSC Manufacturing Platform
REPROCELL Japan Overview REPROCELL has unveiled a robust iPSC manufacturing scale-up strategy aimed at accelerating clinical development and commercialization of iPSC-based therapeutics. Their StemRNA™ Clinical iPSC Platform offers clini... -
University of Toronto Develops Next-Gen RNA Therapy Using Engineered tRNA to Bypass Premature Stop Codons, Offering Hope for Thousands of Untreatable Genetic Diseases
University of Toronto Canada Overview Researchers at the University of Toronto have developed a groundbreaking next-generation RNA therapeutic approach that enables cells to 'read through' disease-causing premature termination codons (PT...
